R Rimondini

Author PubWeight™ 21.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998 6.27
2 Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A 2000 1.38
3 Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. Neuroreport 1997 1.06
4 c-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region. J Neurosci 2003 1.05
5 Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci Lett 2002 1.02
6 Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease. Parkinsonism Relat Disord 2001 0.95
7 Modulation of voluntary ethanol consumption by beta-arrestin 2. FASEB J 2008 0.94
8 Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption. Neuropsychopharmacology 2001 0.92
9 Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats. Alcohol Clin Exp Res 2001 0.87
10 Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum. Neuropharmacology 1999 0.82
11 Plasticity and impact of the central renin-angiotensin system during development of ethanol dependence. J Mol Med (Berl) 2007 0.81
12 The NMDA positive modulator D-cycloserine inhibits dopamine-mediated behaviors in the rat. Neuropharmacology 1994 0.80
13 Leptin suppression of hypothalamic NPY expression and feeding, but not amygdala NPY expression and experimental anxiety. Pharmacol Biochem Behav 2002 0.79
14 Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour. Eur J Neurosci 1999 0.79
15 Intrastriatally injected c-fos antisense oligonucleotide interferes with striatonigral but not striatopallidal gamma-aminobutyric acid transmission in the conscious rat. Proc Natl Acad Sci U S A 1996 0.78
16 Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms. Neuroscience 1996 0.78
17 Age-related alteration of the adenosine/dopamine balance in the rat striatum. Brain Res 1998 0.78
18 Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats. Psychopharmacology (Berl) 1996 0.76
19 The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function. Psychopharmacology (Berl) 1995 0.75
20 [Hepatic, splenic and pancreatic calcifications. Observations on 2 cases]. Minerva Med 1972 0.75
21 [Problems of infection complications encountered at the resuscitation and intensive care center]. Minerva Anestesiol 1974 0.75
22 [Psychology of the driver]. Boll Soc Med Chir Cremona 1966 0.75
23 Repeated administrations of (-)-deprenyl increase [3H]MK801 binding in rat brain and antagonize the impairment of passive avoidance conditioning induced by N-methyl-D-aspartate receptor antagonists. Neurosci Lett 1994 0.75
24 [The Zimmer test (two dye test) in primary hepatic diseases]. Bull Sci Med (Bologna) 1969 0.75
25 [Statistical considerations on some laboratory methods: glycemia and azotemia. I. Determinations in normal subjects]. Bull Sci Med (Bologna) 1970 0.75
26 [Correlations between the results of Raven's progressive matrices, of the Wechsler-Bellevue scale and of color naming in a group of 100 young persons in Cremona Province]. Boll Soc Med Chir Cremona 1966 0.75
27 Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats. Pharmacol Res 1997 0.75
28 [Pheochromocytoma (description of an unusual clinical case)]. Acta Gerontol (Milano) 1972 0.75
29 [Congenital coagulation disorders caused by combined deficiency of factor VIII and factor IX (hemophilia AB)]. Bull Sci Med (Bologna) 1972 0.75
30 [Findings with characterologic and personality tests in children with underweight-type growth disorder (thinness)]. Boll Soc Med Chir Cremona 1966 0.75
31 D-cycloserine decreases both D1 and D2 dopamine receptors number and their function in rat brain. Pharmacol Biochem Behav 1994 0.75
32 [Contribution to the study of the urinary elimination of placental gonadotropins in the diagnosis of pregnancy]. Bull Sci Med (Bologna) 1966 0.75
33 "Atypical" neuromodulatory profile of glutapyrone, a representative of a novel 'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studies. Eur Neuropsychopharmacol 1998 0.75
34 The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology 1992 0.75
35 [Behavior of certain parameters of lipid metabolism and blood coagulation in dyslipidemic patients fed a low-fat diet]. Acta Gerontol (Milano) 1972 0.75
36 [Post-tachycardia syndrome]. Minerva Cardioangiol 1970 0.75
37 [Electrocardiographic changes in acute viral hepatitis]. Minerva Cardioangiol 1968 0.75